Quality of Life in Food Allergy: Validation of Three Mini-questionnaires
NCT ID: NCT06112873
Last Updated: 2023-11-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
600 participants
OBSERVATIONAL
2023-11-05
2025-11-05
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The target population of the questionnaires will be:
i) the parents of allergic children 0 to 17 years (15 questions) ii) allergic children aged 8 to 17 years (13 questions) iii) Adults over 18 (14 questions)
After receiving an information note, eligible patients or their parents will complete the questionnaires. A total of 200 patients will be recruited for each questionnaire.
A statistical evaluation will be carried out using 200 questionnaires for each targeted population in order to validate the psychometric properties of the questionnaire as well as investigate the degree of correlation between the scores of the mini-questionnaire and those obtained using the Europrevall reference questionnaire.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Assessment of Quality of Life in Food Allergic Children
NCT01480427
Health Related Quality of Life in Children With Food Allergy: Comparison to Controls and Other Chronic Diseases
NCT02008643
Master Allergen Child Nutrition. Reintroduction of Small Doses
NCT02384707
Evaluation of The Food Allergy Mastery Program
NCT06034678
The Quality of Life of Mothers of Children With Food Allergy
NCT04740632
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The selected items are divided into three areas: i) social and food limitations; ii) food anxiety; and iii) the risks of accidental ingestion. A statistical evaluation will be carried out using 200 questionnaires for each targeted population in order to validate the psychometric properties of the questionnaire as well as investigate the degree of correlation between the scores of the mini-questionnaire and those obtained using the Europrevall reference questionnaire.
Study Procedures :
After receiving an information note, eligible patients and/or their parents will complete the questionnaires.
Outcome measures:
Patient-Reported Outcomes via specific questionnaires
Participant numbers:
200 patients will be recruited for each questionnaire
Participants and recruitment:
Inclusion criteria :
Patient or parent of a patient with an IgE-mediated allergy to any food, or a non-IgE-mediated allergy to cow's milk in infants.
Exclusion criteria :
All patients who do not fit the inclusion criteria mentioned above, lack of consent, mental or visual disturbances, not understanding the questionnaire language.
Resources :
This multicenter study will be conducted at CHU de Besançon, CHU de Toulouse, CHU Angers and CHU de Lyon.
Data management:
Data will be collected directly from the patients. All paper patient records will be kept in locked filing cabinet. Electronic files will be saved on password protected folder
Oversight :
i) Data will be entered from a professional computer station; ii) all documents containing the identity of the participating subjects (non-objection, list of correspondence, etc.) will be kept away from personal data; iii) if it is a paper document, it will be stored in a secure location known only to professionals involved in the research ; iv) If it is a computerized document, it will be kept on the center's information server with access control by password.
References:
1- Doc, A., Capelli, E., Le Pabic, F., Pouessel, G., Deschildre, A., Morisset, M., \& Rame, J. M. (2020). Allergodiet: un groupe de travail de diététiciens nutritionnistes en allergologie. Revue Française d'Allergologie, 60(3), 143-149.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
OTHER
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
The parents of allergic children 0 to 17 years
The parents of 200 eligible patients will complete the parent questionnaire comprising 15 questions
Quality of Life Questionnaire
Patient (or Parent)-Reported Outcomes via specific questionnaires
Allergic children aged 8 to 17 years
A total of 200 eligible patients aged 8 to 17 years will complete the children's self-reported questionnaire comprising 13 questions.
Quality of Life Questionnaire
Patient (or Parent)-Reported Outcomes via specific questionnaires
Adults over 18
A total of 200 adult patients will complete the adult self-reported questionnaire comprising 14 questions.
Quality of Life Questionnaire
Patient (or Parent)-Reported Outcomes via specific questionnaires
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Quality of Life Questionnaire
Patient (or Parent)-Reported Outcomes via specific questionnaires
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Angers
OTHER_GOV
University Hospital, Toulouse
OTHER
Hospices Civils de Lyon
OTHER
Centre Hospitalier Universitaire de Besancon
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2023/818
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.